Stay updated on Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for a Phase 2 trial of cabozantinib in Japanese participants with advanced hepatocellular carcinoma is displayed, including its design, eligibility criteria, outcome measures, locations, and study documents.
    Difference
    63%
    Check dated 2026-11-07T12:19:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T12:53:49.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    An NIH announcement about changes to NIH websites appears above the 403 error message.
    Difference
    1%
    Check dated 2026-10-24T12:29:34.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:34:35.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T15:27:56.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study record content with a generic error view. Previously visible content such as PDFs, SAP, protocol, and location details are no longer accessible on the page.
    Difference
    19%
    Check dated 2026-09-19T18:28:43.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Hepatocellular Carcinoma Clinical Trial page.